(Marcor, Hackensack, NJ, USA), Bacto peptone 5 g, yeast extract 2 g and NaCl 1 g in 1 l tap water; the pH was adjusted to 7.3 before sterilization. The fermentor was inoculated with 5% by volume of shake flask cultures grown in the same medium at 27 1C in 500 ml Erlenmeyer flasks with a single baffle for 48 h on a rotary shaker at 120 r.p.m. The fermentation was carried out for 48 h with an aeration rate of 0.5 volume air/ volume/min and agitation at 1 000 r.p.m. Production of compounds 1-4 started at about 20 h and reached a maximal yield of 394 mg l À1 after an incubation period of 48 h. Compounds 1-4 were isolated from the mycelium by extraction with Me 2 CO. After concentration to an aqueous residue, 1-4 were re-extracted by ethyl acetate and separated by column chromatography on Florisil (E Merck, Darmstadt, Germany) with CH 2 Cl 2 -MeOH (50:1) to give 180 mg of 1-4 containing fractions. Separation of 1-4 into single compounds was achieved by semi-preparative reversed-phase HPLC on Grom-Sil 300 ODS-5 (250Â20 mm, 10 mm; Alltech-Grom, Rottenburg, Germany) and linear gradient elution H 2 O-CH 3 CN (57-61% CH 3 CN within 39 min) at a flow rate of 15 ml min À1 . The fractions yielded 1 (1.68 mg), 2 (3.77 mg), 3 (2.23 mg) and 4 (1.59 mg).
The mass spectra derived from the HPLC-ESI-MS analysis revealed molecular masses for 1 ((M+H) + ¼362.4), 2 ((M+H) + ¼364.4), 3 ((M+H) + ¼378.4) and 4 ((M+H) + ¼380.4). This led to the assumption that the differences in structure between 1, 2 and 3, 4 were due to the presence or absence of double bounds, and compared to structures 1 and 2, compounds 3 and 4 might have an additional oxygen.
The structures of the compounds were fully elucidated by extensive 1D and 2D NMR analyses. The FT-ICR-MS (m/z 362.24777) data of 1 indicated its molecular formula to be C 25 H 31 NO ((M+H) + theor ¼362.24784; Dm¼0.19 p.p.m.). Furthermore, the 1 H-NMR and HSQC data of 1 showed a total of 30 carbon-attached protons, of which 5 methyl, 3 methylene and 9 methine carbons could be assigned. Inspection of the 2D-NMR data (COSY, TOCSY, HSQC and HMBC) showed the structure of 1 to be a new metabolite, aurachin Q (Figure 2a) . The complete NMR assignments were unambiguously carried out on the basis of COSY, TOCSY and HMBC experiments. The FT-ICR-MS (m/z 378.24277) data of 3 indicated its molecular formula to be C 25 H 31 NO 2 ((M+H) + theor ¼ 378.24276; Dm¼0.03 p.p.m.). By comparison with the NMR data of compound 1, the structure could be assigned as its N-hydroxy derivative, aurachin R (3; Figure 2a ).
The molecular formula of 2 was determined by FT-ICR-MS (m/z 364.26351) data to be C 25 H 33 NO ((M+H) + theor ¼364.26349; Dm¼0.05 p.p.m.). By comparison with the NMR data of compound 2, the structure could be assigned to be aurachin D (Figure 2b Tables 1 and 2 .
Comparison of the COSY spectra of 1 and 2 showed that a structural difference could only be seen at the H-4¢ and H-5¢ positions; these protons are methylene protons in 2 compared to methine protons in 1. The structural differences of 3 and 4 could be assigned to the N-hydroxy derivatives of 1 and 2 due to the different 13 C shifts deduced from the HMBC neighboring the nitrogen atom. Members of the aurachin family were first isolated from the myxobacterium Stigmatella aurantiaca. 4, 5 Recently, aurachin RE, which is similar in structure to that of aurachin C with a hydroxy group in position C-9¢ of the hydrocarbon chain was isolated from a culture broth of R. erythropolis JCM 6824. 6 The aurachin structures are characterized by a bicyclic quinoline core system that is connected to an isoprenoid chain in various positions. In biological assays aurachins show growth inhibitory activity against numerous Gram-positive bacteria and weak antifungal activity. Aurachin C (4) and D (2) have been extensively studied as they strongly inhibit the quinol oxidation sites of Escherichia coli, that is, cytochromes bo and bd. 7 Isomers of 2 have been used for electron transfer studies to further characterize the cytochrome oxidase bd from Azotobacter vinelandii. 8 The different selectivities of 4-the N-hydroxy derivative of 2-and 2 toward cytochromes bd and bo of E. coli make them a unique model system to study the selectivity of these oxidases.
Compounds 1-4 were tested for antimicrobial activity against several Gram-positive and Gram-negative bacteria using a resazurinbased assay. Compounds 3 and 4 showed moderate antibacterial activity (70-89% growth inhibition at 100 mM) against Staphylococcus epidermidis DSM 20044, Bacillus subtilis DSM 347 and Propionibacterium acnes DSM 1897, whereas compounds 1 and 2 were found to be inactive up to a concentration of 100 mM. Gram-negative bacteria, such as E. coli K12 DSM 498, Pseudomonas fluorescens NCIMB 10586, P. aeruginosa DSM 50071 and Xanthomonas campestris DSM 2405 were not susceptible to compounds 1-4. Interestingly, compounds 3 and 4 showed weak inhibitory activity against glycogen synthase kinase 3b at a concentration of 10 mM (19 and 22% inhibition, respectively). Measurement of the glycogen synthase kinase 3b activity was adapted from a luminescent assay described by Baki et al. 9 
